TO THE, — Ibrutinib Importer Profile
Pharmaceutical Importer · #1 buyer for Ibrutinib · $147.4K import value · 42 shipments · BRAZIL · DGFT Verified
TO THE, is the #1 importer of Ibrutinib from India with $147.4K in import value and 42 verified shipments. TO THE, holds a 14.2% market share in Ibrutinib imports based in BRAZIL. The company sources from 2 verified suppliers across 24 formulations shipped to 2 countries. Overall, TO THE, imports 11 pharmaceutical products worth $930.0K across 4 therapeutic categories.
TO THE, — Ibrutinib Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ibrutinib to TO THE,?
Verified from 42 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| VAMA LIFECARE PRIVATE LIMITED | $139.8K | 38 | 94.8% |
| JPC GLOBAL | $7.6K | 4 | 5.2% |
TO THE, sources Ibrutinib from 2 verified Indian suppliers based on 42 customs records. The primary supplier is VAMA LIFECARE PRIVATE LIMITED accounting for 94.8% of imports.
How Does TO THE, Compare to Nearest Ibrutinib Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | TO THE, ★ | BRAZIL | $142.8K | 39 | $3.7K |
| 2 | VALTER LUIZ CACHELLI | BRAZIL | $70.8K | 2 | $35.4K |
| 3 | ACI LOGISTICS DWC LLC | UKRAINE | $55.8K | 2 | $27.9K |
TO THE, ranks #1 among 210 Ibrutinib importers from India. Average shipment value of $3.7K compared to the market average of $2.3K. The closest competitors by value are VALTER LUIZ CACHELLI and ACI LOGISTICS DWC LLC.
Where Does TO THE, Import Ibrutinib To?
Destination countries from 42 verified shipments
TO THE, imports Ibrutinib to 2 countries. The primary destination is BRAZIL receiving 94.8% of shipments worth $139.8K.
What Ibrutinib Formulations Does TO THE, Import?
| Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140MG BRAND NAME: CAPS. IMBRUVICA 140MG, BATCH NO: NDS0K00 (CAPS/NOS | $22.5K | 4 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140 MG , BRAND NAME: IMBRUVICA 140 MG , BATCH NO. PFS0B00 (PACK=N | $21.2K | 5 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140 MG, BRAND NAME: IMBRUVICA 140 MG , BATCH NO. PFS0B00 (PACK=NO | $17.4K | 4 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140 MG, BRAND NAME: IMBRUVICA 140 MG , BATCH NO. PHS0100 (PACK=NO | $12.9K | 3 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140 MG, BRAND NAME: IMBRUVICA 140 MG , BATCH NO. PHS0000 (PACK=NO | $12.8K | 3 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140MG BRAND NAME:CAPS. IMBRUVICA 140MG, BATCH NO: NGSOA00 (CAPS/PNOS | $11.3K | 2 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140MG, BRAND NAME: CAPS.IMBRUVICA 140MG, BATCH NO: NGS0A00 (CAPSNOS | $5.6K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS. IBRUTINIB 140MG BRAND NAME: CAPS.IMBRUVICA 140MG, BATCH NO. MJS0K00 (CAPS | $5.6K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS. IBRUTINIB 140MG, BRAND NAME: CAPS.IMBRUVICA 140MG, BATCH NO: NGSOA00 (CAPNOS | $5.6K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140MG, BRAND NAME: CAPS.IMBRUVICA 140MG, BATCH NO: NBS2X00 (CAPSNOS | $5.6K | 1 |
TO THE, imports 24 distinct Ibrutinib formulations from India. The top formulation is HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS.IBRUTINIB 140MG with 4 shipments worth $22.5K.
Regulatory Requirements: Importing Ibrutinib into Brazil
What TO THE, and other importers must comply with to import Ibrutinib from India
Regulatory Authority
Brazilian Health Regulatory Agency (ANVISA)
Approval Process for Generic Ibrutinib
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
GMP Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Import Licence & Documentation
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Labeling & Packaging
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ibrutinib from India and How Much Does TO THE, Import?
India exported $477.3K worth of Ibrutinib through 560 shipments from 103 suppliers to 60 countries, serving 210 buyers globally. TO THE, imports $147.4K of this total, accounting for 14.2% of India's Ibrutinib exports with 42 shipments from BRAZIL. This is verified from 42 customs shipment records covering 24 distinct formulations.
What Is the Average Order Value for TO THE,'s Ibrutinib Imports?
TO THE,'s average Ibrutinib order value is $3.5K per consignment, based on 42 shipments totaling $147.4K. TO THE, is based in BRAZIL and ranks #1 among all Ibrutinib importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Ibrutinib to TO THE,?
TO THE, sources Ibrutinib from 2 verified Indian suppliers: VAMA LIFECARE PRIVATE LIMITED ($139.8K, 94.8%), JPC GLOBAL ($7.6K, 5.2%). This is based on 42 customs records.
How Does TO THE, Compare to Other Ibrutinib Importers?
TO THE, ranks #1 among 210 Ibrutinib importers from India with a 14.2% market share. The top 3 importers are TO THE, ($142.8K), VALTER LUIZ CACHELLI ($70.8K), ACI LOGISTICS DWC LLC ($55.8K). TO THE, processed 42 shipments from BRAZIL.
What Other Advanced Oncology Products Does TO THE, Import?
TO THE, also imports these advanced oncology products. Each links to the detailed product page.
About TO THE,
TO THE, imports 11 products worth $930.0K. Beyond Ibrutinib, top products include Cyclophosphamide, Semaglutide, Empagliflozin, Linagliptin, Canagliflozin. View the complete TO THE, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ibrutinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ibrutinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TO THE, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TO THE,'s capped import value divided by total capped export value for Ibrutinib across all Indian exporters.
- 5.Verified Records: This page is backed by 42 individual customs records matching TO THE, importing Ibrutinib, covering 24 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 60+ countries, 210+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ibrutinib Import Data for TO THE,
Access order-level details, pricing data, supplier connections, and competitive analysis for TO THE,'s Ibrutinib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TO THE,
Full Company Profile →
11 products · $930.0K total trade · 4 categories
TO THE, × Ibrutinib
Verified from customs records
Company Overview
Top Products by TO THE,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TO THE,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ibrutinib. For current order-level data, contact TransData Nexus.